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Summary
Objective: The purpose of the study was to determine whether the implantation of a scaffold would facilitate cartilage repair after microfracture
in sheep over a period of 12 months. Furthermore, we investigated the effect of additional autologous cell augmentation of the implanted
constructs.
Methods: Two chondral defects were produced in the medial femoral condyle of sheep without penetrating the subchondral bone. Twenty-
seven sheep were divided into the following groups: seven served as untreated controls (Group 1), microfracture was created in 20 animals,
seven of them without further treatment (Group 2), in six sheep the defects were additionally covered with a porcine collagen matrix (Group 3),
and in seven animals the matrix was augmented with cultured autologous chondrocytes (Group 4). After 4 (11 sheep) and 12 months (16
sheep), the ﬁlling of the defects, tissue types, and semiquantitative scores were determined.
Results: The untreated defects revealed the least amount of defect ﬁll. Defects treated with microfractures achieved better defect ﬁll, while the
additional use of the matrix did not increase the defect ﬁll. The largest quantity of reparative tissue was found in the cell-augmented group.
Semiquantitative scores were best in the cell-augmented group.
Conclusion: Microfracture treatment was observed to enhance the healing response. The implantation of a cell-seeded matrix further
improved the outcome. The implantation of a collagen matrix alone did not enhance repair. Autologous cell implantation appears to be a very
important aspect of the tissue engineering approach to cartilage defects.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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International
Cartilage
Repair
SocietyIntroduction
Traditional surgical marrow stimulation techniques such as
microfracture proved to be successful for the treatment of
small defects, as they promoted the creation of ﬁbrocarti-
laginous repair tissue1e3. However, the tissue tends to be
mechanically soft and degenerates with time4.
Autologous chondrocyte transplantation5 (ACT) encour-
aged the production of hyaline-like cartilage in the knee and
ankle joint and thus achieved durable results in the midterm
follow-up as well as in experimental studies6e10. It appears
to provide a three-dimensional environment that facilitates
the maintenance of the chondrocytic phenotype11. Besides,
various scaffolds are used as carriers for the implantation of
cells into cartilage defects12e15. The substance should have
a composition that maintains the chondrocyte phenotype,
and a pore structure that accommodates cell inﬁltration.
Furthermore, the scaffold needs to be mechanically stable
for surgical handling.
Based on these requirements, a multi-layer three-
dimensional scaffold was developed. The scaffold yields a
medium for cell attachment, thus maintaining the phenotype
of chondrocytes over time16e18 as well as delivering a dense
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Received 10 December 2004; revision accepted 4 April 2005.65superﬁcial layer whose purpose is to keep the cells in the
defect and limit the migration of inﬂammatory proteins into
the repair site.
The hypothesis investigated in the present study was that
this additionally implanted three-dimensional scaffold may
yield a supportive construct for chondrocytic differentiation
of chondroprogenitor cells derived from bone marrow by the
stimulation technique until the retrieved tissue achieves
resistance against tangential forces.
The aim of the study was to evaluate the quantity and
quality of the healing response of microfracture-treated
chondral defects combined with a collagen matrix com-
pared to microfracture alone and a technique using
augmented autologous chondrocytes in a sheep model
over a period of 12 months. We present the long-term
results based on our published in vitro data and 4-month
animal data19.
Material and methods
COLLAGEN MATRICES
The matrices (Geistlich Biomaterials, Wolhusen, Switzer-
land) are made of porcine collagen. The dense side
consists of type I and type III collagen that has a rough
side and a smooth side which serves as the surface facing
the articular cavity. The two collagen types can be
distinguished by their different ﬁbrillar size and electron5
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and serves the cell-seeding process. Unseeded and
chondrocyte-seeded matrices have been tested and pre-
sented in previous in vitro studies conducted by our group;
porosity was shown to be 67% in the type I/III layer and 83%
in the type II collagen layer22,23. The actual manufacturing
process of the matrices is the conﬁdential and proprietary
information of the company. The collagen matrices were
delivered single packed after gamma irradiation in round
shape (5 mm diameter by 2e3 mm thick).
ANIMAL EXPERIMENT
Twenty-seven adult (3e5 years old) Austrian sheep
weighing on average 78 kg were used for this investigation.
The experiments were performed in accordance with the
Austrian law for animal experiments (GZ: 66.009/180-Pr/4/
2001) and the guidelines of the European Convention for
the Protection of Vertebrate Animals Used for Experimental
and Other Scientiﬁc Purposes. After a 24-h fast and pre-
medication, the sheep were given thiopentone (25 mg/kg),
incubated, and ventilated with O2 in N2O by volume control.
Anesthesia was maintained with 1.5e2 vol% isoﬂurane;
a bolus dose of 0.1 mg fentanyl was given prior to surgery.
The animals received 2.5 g metamizol and 1 g cefazoline
twice daily until the third postoperative day. The stiﬂe joint of
the right hind leg was sterilely opened by an anteromedial
approach. Using a 4.5-mm punch (SmithCNephew, And-
over, MA), two defects, 1 and 2.5 cm distal from the
intercondylar notch, were created on the medial condyle of
the femur. The defects were outlined with the punch down
to the tidemark bone by soft pressure and the cartilage was
removed with small curettes. Intraoperatively, no bleeding
from the subchondral bone was observed. Following wound
closure, the stiﬂe and ankle joints were ﬁxed with an
external plaster (Scotch/Soft Cast, 3M-Health-Care, St.
Paul, MN) for 5 days, and cage activity was limited. After
removal of the plaster, the sheep were allowed to move
freely. Joint disease was excluded by preoperative radio-
logical examination.
Treatment groups
Fifty-four defects were assessed in 27 sheep that were
divided into four treatment groups. Eleven animals were
sacriﬁced 4 months after implantation and 16 animals, 12
months after implantation. Two other defects in one sheep
that was sacriﬁced for non-surgery-related reasons were
evaluated 5 days after performing microfracture and
implanting an unseeded matrix (short-term implant control
defects).
Group 1: Untreated defects. In 14 defects in seven sheep,
the chondral defects were created in the condyle as
described above and left untreated.
Group 2: Microfracture. In 14 defects, four microfractures
were introduced in each case immediately after the defect
had been created, and no further treatment was applied
(seven animals). The microfractures were created with
a curved awl that was forced into the subchondral bone
to a depth of approximately 2 mm until bleeding was
observed.
Group 3: Unseeded collagen matrices with microfracture e
12 defects. In six sheep the defects were treated bymicrofracture, and unseeded matrices were implanted by
suturing the type I/III layer of the 5-mm disc with 6-0 Vicryl to
the adjacent cartilage at four points.
Group 4: Collagen matrix seeded with autologous chon-
drocytes and microfracture e 14 defects. In seven sheep
the contralateral left stiﬂe joint was opened under general
anesthesia as described above, and small pieces of
cartilage were harvested from the low-weight-bearing
surfaces of the trochlea and the intercondylar notch. The
cartilage was cut superﬁcially with a scalpel to avoid
bleeding. Specimens were rinsed and stored in Dulbecco’s
modiﬁed Eagle’s medium (Life Technologies, Grand Island,
NY) supplementedwith penicillin/streptomycin (10,000 U/ml)
(PAA Laboratories, Linz, Austria), 10% fetal calf serum (PAA
Laboratories) and 0.05 mg/ml ascorbic acid. The cartilage
samples were processed as described previously21. Cells
were cultured inmonolayer for 2e5weeks and passaged two
to three times. When the chondrocytes reached conﬂuence,
they were trypsinized, centrifuged, and resuspended at
a concentration of 2! 107 cells/ml for seeding the matrices.
Discs of thematrix (nZ 3), 5 mm in diameter, were seeded in
a drop-wise fashion with 50 ml of the cell suspension
containing one million chondrocytes. The cells were seeded
onto the more porous side of the sponge consisting of type II
collagen. After 1 h, 1.5 ml of medium was added. The cell-
seeded constructs (nZ 2) were sterilely transferred to the
operating room and implanted within 48 h of seeding into the
right stiﬂe joint after creating two defects and microfractures.
Prior to the seeding process, 0.5 ml of each cell suspension
per sheepwas cultured on chamber slides (Flexiperm,Merck
Eurolab, Zaventem Belgium). After 2e3 days the medium
was discharged, the slides were kept in acetone for 10 min at
4(C, and immunohistochemistry was performed to type II
collagen. In cell-seeded constructs whichwere not implanted
(nZ 1 per sheep), DNA analysis was performed. The
samples were digested in 1 ml of a 0.5% papain/buffer
solution (Sigma, St. Louis, MO, USA) in a 65(C water bath.
An aliquot of a papain digest was assayed ﬂuorometrically
(Wallac, Turku, Finland) using the Hoechst dye no. 33258
(Sigma, St. Louis, MO, USA). The results were extrapolated
from a standard curve using calf thymus DNA23.
Tissue processing and histomorphometry
The sheep were sacriﬁced in general anesthesia using
i.v. thiopentone, followed by potassium chloride, until
cardiac arrest was achieved.
The stiﬂe joints were opened under sterile conditions and
a culture swab was obtained. The swabs were cultured on
two plates for anaerobes, on Columbia agar and MacCon-
key agar. The joint and the synovium were subjected to
gross examination. Specimens of synovial membranes
were used for histological assessment. The distal femur
was removed and placed in 10% neutral buffered formalin.
Areas of trochlea containing the defects were dissected and
subsequently placed in a decalciﬁcation solution [100 g
Tritriplex (Epignost, Leonding, Austria) and 33 g tris-
hydroxymethylene-aminomethane (Merck Eurolab, Zaven-
tem, Belgium) per 1000 ml; pHZ 7.2] at room temperature.
The decalciﬁed specimens were embedded in parafﬁn and
cut into 5-mm sections.
Sections were stained with hematoxylin and eosin,
safranin-O/fast green, Alcian blue and Azan blue for
histomorphometric assessment of tissue types. Immuno-
histochemistry with antibodies for type I and type II
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ing to a standard ABC protocol, using an AvidineBiotin
Blocking Kit (Vector Laboratories INC, Burlingame, CA,
USA). Type I and type II antibodies (horse anti-goat
collagen I and II) were provided by Southern Biotechnology
Ass. Inc., AL, USA. Synovial membranes were stained with
hematoxylin and eosin.
Light microscopy was performed on a Vanox Olympus
research microscope using a histomorphometric method to
determine the areal percentage of selected tissue types9.
Multiple serial sagittal histological sections from the middle
portion of the defect were assessed. The histomorphomet-
ric assessment was performed using the software program
analySIS 3.0 (Soft Imaging System GmbH, Mu¨nster,
Germany). The area of the defect was determined by
marking its borders to the defect base and the adjacent
cartilage, and calculating the area size. Defect ﬁlling was
determined in terms of the areal percentage of reparative
tissue in the defect, based on three cross-sectional areas in
a sagittal plane through the center of the lesion, as
previously described9,18,19,24.
Criteria for distinguishing tissue types and the
degree of integration of reparative tissue
Tissue types (bone, ﬁbrous tissue, transitional tissue,
hyaline tissue, articular cartilage) were distinguished
according to previously mentioned criteria for cell and
matrix appearance and the presence of safranin-O staining,
and staining for types I and II collagen9,18,19,24.
Integration of the reparative tissue into the host was
assessed by quantitative measurement of the linear
percentage (0e100%) of tissue attached to the base of
the lesion and the adjacent cartilage. The percentage of
length of the calciﬁed cartilage layer of normal appearance
was also determined. The ﬂow of adjacent cartilage into the
defect site was measured25.
Two scoring systems were used for histological evalua-
tion. The degree and the quality of healing in all defects
were assessed and scored blindly by the senior author (SN)
and the ﬁrst author (RD), using the repair grading systems
of O’Driscoll et al.26 and Pineda et al.27. The graded
parameters included cellular morphology, surface regular-
ity, structural integrity, bonding to the adjacent cartilage,
height of reparative tissue, and adjacent cartilage degra-
dation. The maximum possible score was 24 points in the
O’Driscoll grading system (minimum 0 points) and 0 point in
the Pineda scoring system (minimum 14 points). The
reliability of both scoring systems has been demonstrated
in recent studies28,29.
STATISTICAL METHODS
The correlation between proximal and distal defects in
one joint was assessed by Spearman’s correlation coef-
ﬁcients; for most variables, proximal and distal defects were
highly correlated. Therefore, the proximal and distal defects
in one joint could not be considered as independent
observations for the purpose of statistical analysis. Aver-
aged data from the two defects in each joint were included
in the statistical calculations.
In order to determine differences between the four
treatments, mixed model analysis was performed for the
target variables ‘‘total defect ﬁll’’, ‘‘O’Driscoll’’ and ‘‘Pineda
score’’ with the ﬁxed factors of treatment and defect. The
random factor ‘‘sheep’’ was included in the model in order to
account for multiple measurements in one sheep. Leastsquare means were calculated for each treatment. All
pairwise comparisons were performed using Tukey’s
adjustment for P-values. For the target variables ‘‘tissue
type’’ and ‘‘collagen II staining’’, KruskaleWallis analyses of
variance and Wilcoxon’s two-sample tests were performed.
P-values! 0.05 were considered to indicate statistical
signiﬁcance. Owing to the smaller number of animals in
the 4-month groups, no statistically signiﬁcant differences
were registered. Comparisons between groups were
assessed descriptively at 4 months.
Results
At the termination of the experiment all animals ambu-
lated normally; no signs of pain or swelling were observed.
After opening the joint, the synovial ﬂuid was found to be
clear in all animals. There was no sign of synovitis either on
gross examination or in histology. No bacterial growth was
found in the swabs taken from the stiﬂe joints at necropsy.
CELL-SEEDED MATRICES
Immunohistochemistry to type II collagen in chamber
slides revealed positive staining consistent with the
chondrocytic phenotype of the transplanted cells in all
seven animals. The DNA analyses of the cell constructs of
the seven animals showed a net DNA amount of 589 ng/mg
of matrixG 117 (meanG standard error of the mean),
demonstrating the presence of cells in the matrices during
the implantation procedure.
GROSS EVALUATION
In all groups, the defects were distinguishable from the
surrounding tissue (Fig. 1). The defects in the control group
were almost unchanged on gross examination while the
defects in the microfracture group appeared mainly with
scar tissue on the defect base and a ﬂow phenomenon that
was more pronounced at the 12-month follow-up. The
defects treated with microfracture and unseeded matrices
appeared similar to those in the microfracture group. The
appearance in the cell-seeded group combined with micro-
fracture was different and ranged from almost no defect ﬁll
(one sheep) to a large quantity of reparative tissue after 4
months. By 12 months, the defects in group 4 had the
largest quantity of reparative tissue, achieving the level of
the adjacent cartilage in some instances. All defects treated
with matrix revealed the suture tracks at both time points.
HISTOLOGICAL EVALUATION (FIGS. 1 – 3)
The results of histological investigation are shown in
Table I. The principal ﬁndings are as follows.
Untreated defects (Group 1)
Group 1 had a total defect ﬁll of 22%G 10 (meanG
standard error of themean) after 4months and 15%G 3 after
12months. The defects revealedmostly ﬁbrous tissue after 4
months and transitional tissue by 12months. The percentage
of the intact calciﬁed layer was high (99%) after 4months and
decreased slightly (to 92%) after 12 months. Degenerative
changes in the adjacent cartilage were most severe in the
untreated group at both time points. TheO’Driscoll scorewas
2.8G 0.8 points after 4 months and 1.4G 0.3 points after 12
months while the Pineda score was 12.0G 0.9 points and
11.7G 0.4 points, respectively (Fig. 3).
658 R. Dorotka et al.: Marrow stimulation and chondrocyte transplantation for cartilage repairFig. 1. Gross and histological specimens of the defects at 4 (left columns) and 12 months (right columns). The representative histological
sections are stained with H.E.: untreated defects in the ﬁrst row (1), microfracture-treated defects in the second row (2), unseeded matrix
combined with microfracture in the third row (3), and microfracture with chondrocyte-augmented matrix in the fourth row (4).Microfracture (Group 2)
Defects treated with microfractures showed 54%G 7
defect ﬁll by 4 months and 73%G 5 defect ﬁll after 12
months. Hyaline cartilage was the predominant tissue type
at 4 months and transitional tissue after 12 months.
Typically, these defects revealed the growth of repair tissue
into the subchondral bone within the microfracture holes.
No bone was seen in the defects after 4 months; however,
after 12 months 8%G 5 of the defects were ﬁlled with bone.
The subchondral bone was intact in 79%G 4 and 33%G 6,
respectively. The O’Driscoll score was 10.6G 1.6 points
after 4 months and 6.5G 0.9 points after 12 months while
the Pineda score was 6.1G 1.1 points after 4 months and
6.1G 0.6 points after 12 months.
Unseeded collagen matrices with microfracture
(Group 3)
Group 3 achieved a defect ﬁll of 43%G 8 after 4 months
and 71%G 4 by 12 months. Transitional tissue was the
predominant tissue type in this group. The subchondral
bone was intact in 65%G 10 in the 4-month group and in
42%G 6 after 12 months. In the latter group, an elevation of
subchondral bone into the defect was observed (6%G 4)
after 12 months. In the O’Driscoll score 5.8G 1.1 points
were achieved after 4 months and 5.8G 0.7 points after 12
months. The Pineda score was 8.2G 0.9 points after 4
months and 6.8G 0.6 points after 12 months. No remnants
of the collagen matrix were found at either time point.
Collagen matrix seeded with autologous
chondrocytes and microfracture (Group 4)
65%G 8 of the defect was ﬁlled with repair tissue after 4
months in Group 4. After 12 months the defect ﬁll increased
to 89%G 2. At the ﬁrst follow-up the largest quantity of
repair tissue was hyaline cartilage (54%G 8); however,after 12 months the most part was transitional tissue
(45%G 6). In some areas of hyaline tissue, a beginning
columnar arrangement of chondrocytes was observed
(Fig. 4). The calciﬁed layer was intact in 54%G 4 in the
4-month group and in 10%G 3 in the 12-month group.
The defects were ﬁlled with 18%G 5 bone at the 1-year
follow-up. This group had an O’Driscoll score of 14.6G 1.5
points after 4 months and 11.6G 1.3 points after 12
months, while the Pineda score was 4.3G 0.8 and
3.4G 0.4 points, respectively.
Volume of the defects filled with reparative tissue
The untreated control defects (Group 1) showed a re-
duction of total defect ﬁll between the two time points of
investigation (Fig. 3). All treatment groups (Groups 2, 3, and
4) revealed a signiﬁcant increase in defect ﬁll from 4 to 12
months (PZ 0.02; Wilcoxon’s two-sample test). The high-
est amount of reparative tissue was found in the cell-
augmented group at both time points (PZ 0.02; Wilcoxon’s
two-sample test). By 12 months Group 1 had signiﬁcantly
less ﬁlling volume compared to all other treatment groups
(PZ 0.03; Wilcoxon’s two-sample test). Moreover, the
difference between Groups 3 and 4 was statistically
signiﬁcant (PZ 0.03; Wilcoxon’s two-sample test).
Tissue types
The untreated defects had signiﬁcantly more ﬁbrous
tissue compared to Group 4 (PZ 0.03; Wilcoxon’s two-
sample test) and less transitional (PZ 0.03) and hyaline
tissue (PZ 0.03) compared to all other groups. Further-
more, Group 4 revealed signiﬁcantly more hyaline tissue
compared to the microfracture group and the unseeded-
matrix groups (PZ 0.03; Wilcoxon’s two-sample test and
PZ 0.005; KruskaleWallis analyses of variance). After 4
months no bone was found in the defects. After 12 months,
subchondral remodeling with osseous growth into the
659Osteoarthritis and Cartilage Vol. 13, No. 8Fig. 2. Histological sections stained with safranin-O/fast green (left column) and immunohistochemistry with antibodies to type II collagen (right
column) in (a) control defects, (b) defects treated with microfracture, (c) defects treated with microfracture and unseeded matrix, and (d)
defects treated with microfracture and cell-seeded matrix.defect was seen in all groups treated with microfractures
(range for all microfracture-treated defects, 0e43%); this
phenomenon was most pronounced in Group 4 (PZ 0.04;
KruskaleWallis analyses of variance).
Semiquantitative scores
After 4 months we found no signiﬁcant ﬁndings between
the groups in respect of the O’Driscoll and the Pineda
scores. After 12 months Groups 1, 2, and 4 had decreased
scores whereas Group 3 had a constant O’Driscoll score.
By 12 months the differences between the untreated group
and the other groups were statistically signiﬁcant (PZ 0.03;Wilcoxon’s two-sample test), as was the difference between
Groups 3 and 4 (PZ 0.03; Wilcoxon’s two-sample test). In
the KruskaleWallis analyses of variance, an overall P-value
of 0.006 was registered for the O’Driscoll score at 12
months. The differences within the groups between month 4
and 12 did not achieve the level of signiﬁcance (Fig. 3).
Short-term implant control defects
Histological sections of the two defects assessed after 5
days revealed disruption of the subchondral bone and only
slightly reduced safranin-O staining of the adjacent carti-
lage. One defect showed remnants of the matrix that
660 R. Dorotka et al.: Marrow stimulation and chondrocyte transplantation for cartilage repairFig. 3. Total defect ﬁll and semiquantitative evaluation according to O’Driscoll and Pineda scores. No signiﬁcant ﬁndings were obtained after 4
months. At 12 months, the differences between the untreated group and the other groups were statistically signiﬁcant (*), as was the difference
between Groups 3 and 4 (z). All treatment groups (Groups 2, 3, and 4) showed signiﬁcantly increasing defect ﬁll from 4 to 12 months (black
bar), whereas the differences within the groups between month 4 and 12 concerning the semiquantitative scoring systems did not meet the
selected signiﬁcance criteria. The maximum possible score is 24 points in the O’Driscoll grading system (minimum 0 points) and 0 point in the
Pineda scoring system (minimum 14 points).bonded to both sides of the cartilage (Fig. 5). No signiﬁcant
signs of ﬂow were seen; however, the chondrocyte columns
of the adjacent cartilage were already oriented towards the
defect site.
Discussion
Microfracture has become one of the most common
techniques in arthroscopic cartilage repair; the subchondral
bone plate is perforated in order to induce blood clot
formation in the defect30. It was hypothesized in a previous
study that microfractures allow pluripotent mesenchymal
cells and growth factors from the marrow space to access
the defect1. This technique led to a greater tissue volume in
animal defects compared to untreated osteochondral
defects, as well as good attachment to the adjacent
cartilage and the underlying bone. Although the tissue
consisted of type II collagen, the quality of the repair tissue
was poor compared to healthy cartilage31,32. Therefore,
hyaline tissue cannot be retrieved in the long term. One of
the purposes of this investigation was to determine whether
the results of microfracture can be improved when only
a three-dimensional environment in the form of a collagen
matrix is provided for bone marrow-derived pluripotent
mesenchymal cells, and whether additionally implanted
autologous chondrocytes would inﬂuence the outcome.
The most important ﬁndings of this animal study are as
follows: (1) better repair was achieved in microfractured
defects than in untreated defects, (2) poorer repair was
achieved when the matrix was added, and (3) autologous
chondrocytes must be present at the defect site in order to
achieve a high amount of defect ﬁll and good tissue quality.
One limitation of the present study was possibly the
fact that the defects were evaluated only histologically and
not with regard to their mechanical properties. However,a recent study showed that one-third of all defects that were
examined by indentation testing were damaged33. We
refrained from mechanical testing particularly because of
the small number of animals investigated. The small
number of animals is a further limitation of the study. Its
strengths, on the other hand, were the use of a large animal
model and the incorporation of 12-month post-surgical data.
UNTREATED DEFECTS
In both, 4- and 12-month defects, there was either no or
minimal spontaneous repair when the subchondral bone
had not been damaged. This has also been observed in
previous studies on chondral defects18,24. These defects
demonstrated the highest grade of degenerative changes,
with hypocellularity and depletion of staining in the adjacent
cartilage. In the ovine model as well, our experiment
conﬁrmed the well known phenomenon of minimal healing
in partial-thickness defects of 4.5 mm diameter34. When the
present study was being designed, defects of larger
diameter were deemed to be of osteoarthritic origin. In
view of the small size of the ovine knee joint, such large
defects appeared to be unsuitable for a chondral defect
model. Chondral defects 4.5 mm in size seem to be
appropriate for use in future studies, as defects of this size
will be less prone to excessive spontaneous healing.
MICROFRACTURE
Opening the defect base by means of just four micro-
fracture holes increased the defect ﬁll and improved the
qualitative results at the defect site at both time points; the
difference after 1 year was statistically signiﬁcant. An
important ﬁnding in all treatment groups subjected to
microfractures was the damaged subchondral bone after
4 months and the remodeling of bone after 1 year, which led
661Osteoarthritis and Cartilage Vol. 13, No. 8T
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.4to an elevation of osseous tissue into the defect site.
Extension of the bone plate beyond the native tidemark was
already observed after 4 months in 3! 3 mm osteochon-
dral defects of rabbits35. In our animals, the growth of repair
tissue through the microfracture holes appeared to protect
the tissue against tangential forces; the ﬁxation resembled
a cog-wheel between newly-formed tissue and subchondral
bone. However, after 1 year the subchondral bone was
remodeled and the bonding between repair tissue and bone
was reduced. This could be one explanation for some of the
delayed failures in microfracture-treated patients. Moreover,
the quality of the tissue ﬁlling the defect decreased from 4 to
12 months, as it did in all other groups as well. In a large
animal study31, microfracture-treated defects revealed
a slightly decreasing amount of hyaline tissue from 4 to
12 months compared to untreated defects. Microfractured
defects were ﬁlled to a signiﬁcantly greater extent; however,
there was no difference in the composition of repair tissue
between the treated and the untreated groups up to 12
Fig. 5. Incipient bonding of reparative tissue (RT) and remnants of
the matrix (arrows) at the adjacent cartilage (AC) 5 days after
suturing the matrix to the defect site and microfracture treatment.
Fig. 4. Beginning columnar arrangement of chondrocytes (arrows)
observed in the cell-augmented group (microfracture plus chon-
drocyte-seeded matrix) at 12 months. (RTZ Repair tissue,
SBZ subchondral bone; Azan staining).
662 R. Dorotka et al.: Marrow stimulation and chondrocyte transplantation for cartilage repairmonths. The elevation of subchondral bone into the defect
site, as observed in all of our microfracture-treated defects
at 12 months, was only seen in three sections in the
previous equine model. The thicker cartilage and calciﬁed
layer in that large animal model might afford an explanation
for the lesser quantity of extending bone compared to the
earlier lapine model35 and our ovine models.
UNSEEDED COLLAGEN MATRICES WITH MICROFRACTURE
Histological investigation revealed the three-dimensional
collagen matrix in one of the short-term implant control
defects, and also early bonding between the matrix and the
adjacent cartilage. Nevertheless, when the collagen matrix
was used together with microfracture, greater defect ﬁll or
improved tissue quality could not be achieved at either time
point. The more evident degenerative changes in the
adjacent cartilage compared to the other treatment groups
may be explained by the four sutures that damaged the
adjacent cartilage on the one hand, and the less defect ﬁll
compared to defects treated with cell-augmented matrix on
the other. In other words, the almost entirely ﬁlled defects of
the cell-augmented group appeared to prevent the sur-
rounding tissue from degeneration.
Similar groups were created in a previous canine study36
in which chondral defects were treated. Instead of the
trilayered type I, II, and III collagen matrix used in our study,
a type II collagen matrix was used in the above mentioned
investigation, and microfracture treatment was compared to
microfracture plus unseeded collagen matrix. The most
signiﬁcant difference in terms of method was that the
implantation of the chondrocyte-seeded collagen matrix was
not combined with microfracture. However, in the above
mentioned study, the unseeded matrix combined with
microfracture was superior to the cell-augmented group.
Collagen matrix seeded with autologous
chondrocytes and microfracture
The best results in our animal study were achieved when
one million cultured autologous chondrocytes were added to
the collagen matrix 48 h prior to implantation. Although
defect ﬁll and scores were signiﬁcantly superior compared to
controls and the unseeded-matrix groups, no signiﬁcant
superiority was observed between the cell-augmented and
the microfracture-only groups. However, the cell-augmented
group revealed better results in all parameters except
bonding at 4 months. In the ﬁrst published clinical
comparison between microfracture technique and ACT37,
both methods led to acceptable short-term clinical results.
On histological examination, however, ACT yielded better
results compared to tissue samples taken from patients
treated with the microfracture technique. The histological
comparison was not statistically signiﬁcant because of the
small number of biopsies. Due to the minimal, largely
non-signiﬁcant differences in clinical and animal studies,
these data suggest that a larger number of defects must
be studied in order to meet the criteria of statistical
analysis.
Previously, it was stated that hyaline cartilage was more
likely to form in defects in which the calciﬁed layer was not
initially penetrated, whereas a damaged calciﬁed layer
allowed greater ﬁlling of the defect, but of ﬁbrocartilaginous
nature36,38. This observation was not conﬁrmed in the
present investigation because the largest quantity of defect
ﬁll and the highest percentage of hyaline tissue were found
in the cell-augmented group, which also underwent micro-
fracture treatment. We are unable to answer the question asto whether autologous chondrocytes may compensate the
disadvantages of a perforated calciﬁed layer with regard to
the quality of repair tissue, or whether it is ﬁnally the
combination of autologous transplanted chondrocytes and
bone marrow cells that causes the increased defect ﬁll and
improved tissue. Moreover, we are unable to provide
information about the relative contribution of different cells
within the collagen matrix after implantation that either
attach to it (chondrocytes) or migrate into it (bone marrow
cells). In previous in vitro studies we showed that
chondrocytes as well as bone marrow cells maintained
their characteristic phenotypes within the collagen matrix for
up to 21 days19,22,23. In a previous study it was suggested
that better results would be achieved in osteochondral
defects treated with a chondrocyte-augmented collagen
matrix when the dense layer of the matrix was packed into
the defect, followed by the cell-seeded layer, in order to
prevent the inﬁltration of ﬁbroblasts from the bone mar-
row38. It was shown that the results are not poorer when
there is no dense component at the defect base to hinder
the entry of bone marrow cells. Although it has not been
proved that the cells of the cambium layer of the periosteum
contribute to chondrogenesis, it was stated in previous work
that the use of a collagen cover instead of the ﬂap had
yielded predominantly ﬁbrocartilage, whereas the periosteal
ﬂap resulted in hyaline cartilage36. The good histological
results in our cell-augmented group also suggest that the
presence of a periosteal ﬂap over cultured chondrocytes is
not necessary in order to increase the amount of hyaline
tissue in a defect.
Another factor that may have affected the results
achieved with the chondrocyte-seeded collagen matrix
used in the present study is the time from matrix seeding
to implantation. In the previous canine study, the matrices
were implanted within 12 h after seeding with cultured
autologous chondrocytes36, whereas in our experiment the
cells were implanted 48 h after the seeding procedure. In
a subsequent dog study it was shown that the implantation
of 4-week-cultured chondrocyte-seeded collagen matrices
led to a signiﬁcantly greater quantity of hyaline tissue
compared to a 12-h culture period33. This could provide an
explanation for the better results achieved in the present
study when the cells were cultured for a longer period of
time.
Although hyaline tissue with beginning columnar arrange-
ment of the chondrocytes was observed in this group after
12 months, the amount of hyaline tissue decreased and the
repair tissue generally deteriorated from 4 to 12 months.
These results are reminiscent of a previous histological
assessment24 of the healing of chondral defects treated
with cultured autologous chondrocytes and periosteum. In
the latter study, a phase of degradation was observed
predominantly at 12 and 18 months. However, the
degradation of the surrounding cartilage in the cell-
augmented defects was not conﬁrmed by our results. In
our experiment, the surrounding cartilage deteriorated only
in those groups in which no autologous chondrocytes were
used.
The highest percentage of bonding to the adjacent
cartilage was seen in the cell-augmented group only at 12
months. At 4 months the bonding of the repair tissue to the
adjacent cartilage was less in our study compared to cell-
augmented (non-microfracture-treated) canine defects in
Breinan’s study36. However, in a further recent investiga-
tion, the bonding of engineered cartilage generated in vitro
from chondrocytes cultured on a biodegradable scaffold
was poorer than that in our cell-augmented group. In the
663Osteoarthritis and Cartilage Vol. 13, No. 8latter study, the generated cartilage composites were press-
ﬁtted into osteochondral defects in rabbits39. This phenom-
enon was also observed in histological sections after
osteochondral cylinder transplantation (mosaicplasty),
whereas in ACT the regenerated tissue was tightly united
with the native cartilage40.
No animals treated with the collagen matrix in our study
revealed signs of synovitis. The absence of any noticeable
synovitis in previous studies using a type II collagen would
indicate that the type II material is not signiﬁcantly
immunogenic18,33,36.
Conclusion
Several animal studies support the thesis that cultured
autologous chondrocytes improve defect ﬁll and the quality
of repair tissue9,18,33,41. Our ﬁndings conﬁrmed the hypoth-
esis that additionally transplanted autologous cultured
chondrocytes are essential in order to achieve a large
amount of defect ﬁll and hyaline repair tissue e at least in
the ovine model up to 12 months. Besides, after 1 year,
defects subjected to microfractures were superior to
untreated chondral defects. The histological outcome could
not be improved by simple and economical implantation of
an additional collagen matrix into a microfractured defect.
Cytokines are known to affect the phenotype and the
bioactivity of chondrocytes and bone marrow cells. There-
fore, future studies may well include the application of
speciﬁc growth factors or the incorporation of genes for in
situ transfection and the production of proteins within the
implanted scaffold. Besides, a collagen matrix in combina-
tion with marrow stimulation, but no further autologous
cultured chondrocytes, might be used to facilitate repair.
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